Neuroretinal thickness and macular vessel density decline as part of normal aging, mimicking some signs of glaucoma.
Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and ...
Ocugen has announced positive preliminary 12-month data from its phase 2 ArMaDa trial evaluating OCU410 (AAV5-RORA) for the ...
What are the signs that show I need cataract surgery? “There are several key signs that someone may need cataract surgery,” ...
Check out our latest jolly merch at For brand partnerships and enquiries please email [email protected] Special thanks ...